Icu Medical (ICUI) Research & Development (2009 - 2026)

Icu Medical (ICUI) has reported Research & Development for 18 consecutive years, with $22.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Research & Development rose 3.82% year-over-year to $22.7 million; the trailing twelve-month figure through Jun 2026 stood at $86.3 million (down 2.51% YoY), and the FY2025 full-year result was $87.5 million, down 1.26% from the prior year.
• Research & Development grew to $22.7 million in Q2 2026 per ICUI's latest filing, from $21.3 million in the prior quarter.
• Across five years, Research & Development topped out at $23.9 million in Q1 2022 and bottomed at $19.8 million in Q1 2023.
• Historically, Research & Development has averaged $22.1 million across 5 years, with a median of $22.3 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Research & Development surged 122.91% in 2022, then decreased 17.22% in 2023.
• Over 5 years, Research & Development stood at $23.4 million in 2022, then slipped by 4.41% to $22.4 million in 2023, then fell by 0.25% to $22.4 million in 2024, then slipped by 5.68% to $21.1 million in 2025, then advanced by 7.66% to $22.7 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $22.7 million, $21.3 million, and $21.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.